LT5589B - N-karbamoilmetil-4-(r)-fenil-2-pirolidinonas, jo gavimo būdas ir farmacinis panaudojimas - Google Patents
N-karbamoilmetil-4-(r)-fenil-2-pirolidinonas, jo gavimo būdas ir farmacinis panaudojimas Download PDFInfo
- Publication number
- LT5589B LT5589B LT2008075A LT2008075A LT5589B LT 5589 B LT5589 B LT 5589B LT 2008075 A LT2008075 A LT 2008075A LT 2008075 A LT2008075 A LT 2008075A LT 5589 B LT5589 B LT 5589B
- Authority
- LT
- Lithuania
- Prior art keywords
- pyrrolidinone
- phenyl
- carbamoylmethyl
- compound
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LVP-06-45A LV13630B (en) | 2006-03-16 | 2006-03-16 | Method of preparation and use of pharmaceutically active n-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone |
Publications (2)
Publication Number | Publication Date |
---|---|
LT2008075A LT2008075A (en) | 2009-06-25 |
LT5589B true LT5589B (lt) | 2009-08-25 |
Family
ID=38461010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LT2008075A LT5589B (lt) | 2006-03-16 | 2008-09-22 | N-karbamoilmetil-4-(r)-fenil-2-pirolidinonas, jo gavimo būdas ir farmacinis panaudojimas |
Country Status (21)
Country | Link |
---|---|
US (2) | US9102615B2 (fr) |
EP (1) | EP2013166B1 (fr) |
CN (1) | CN101448786A (fr) |
AT (1) | ATE460396T1 (fr) |
CA (1) | CA2647206C (fr) |
CY (1) | CY1110170T1 (fr) |
DE (1) | DE602007005244D1 (fr) |
DK (1) | DK2013166T3 (fr) |
EA (1) | EA014668B1 (fr) |
EE (1) | EE05536B1 (fr) |
ES (1) | ES2342024T3 (fr) |
GE (1) | GEP20104915B (fr) |
HR (1) | HRP20090524C1 (fr) |
LT (1) | LT5589B (fr) |
LV (1) | LV13630B (fr) |
ME (1) | ME01192B (fr) |
PL (1) | PL2013166T3 (fr) |
PT (1) | PT2013166E (fr) |
SI (1) | SI2013166T1 (fr) |
UA (1) | UA96440C2 (fr) |
WO (1) | WO2007104780A2 (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LV14346B (lv) * | 2009-11-05 | 2011-07-20 | Grindeks, A/S | 2-(4-Fenil-5-metil-2-oksopirolidin-1-il)-acetamīda 4R,5S-enantiomērs ar nootropo aktivitāti |
EP2694474A1 (fr) * | 2011-03-11 | 2014-02-12 | Grindeks | Enantiomère 4r,5r du 2-(5-méthyl-2-oxo-4-phénylpyrrolidine-1-yl) acétamide à activité nootropique |
RU2480214C1 (ru) * | 2011-09-22 | 2013-04-27 | Валентина Ивановна Ахапкина | Состав, обладающий модуляторной активностью с соразмерным влиянием, фармацевтическая субстанция (варианты), применение фармацевтической субстанции, фармацевтическая и парафармацевтическая композиция (варианты), способ получения фармацевтических составов |
CN104350063B (zh) | 2012-05-08 | 2018-01-05 | 尼科斯眼药公司 | 疏水性治疗剂的制剂、其制备方法及应用 |
TW201408294A (zh) | 2012-07-05 | 2014-03-01 | Merz Pharma Gmbh & Co Kgaa | (r)-苯基披喇瑟盪於治療帕金森氏症之用除 |
TW201408293A (zh) | 2012-07-05 | 2014-03-01 | Merz Pharma Gmbh & Co Kgaa | (r)-苯基披喇瑟盪於治療疾病相關疲勞之用途 |
LV15003B (lv) * | 2013-10-22 | 2015-08-20 | Latvijas Organiskās Sintēzes Institūts | Farmaceitiska kompozīcija ķermeņa masas pieauguma kontrolei |
LV15015B (lv) | 2013-12-13 | 2015-12-20 | Olainfarm, A/S | 3-karboksi-4-(R)-fenilpirolidin-2-ona sāls un tā pielietošana |
LV15016B (lv) * | 2013-12-18 | 2016-01-20 | Olainfarm, A/S | N-karbamoilmetil-4(R)-fenil-2-pirolidinona polimorfās formas |
EP2891491A1 (fr) | 2014-01-03 | 2015-07-08 | Merz Pharma GmbH & Co. KGaA | Utilisation de (r) -phénylpiracétame pour le traitement de troubles du sommeil |
LV15072B (lv) | 2014-05-14 | 2016-09-20 | Olainfarm, A/S | Farmaceitiska kompozīcija izmantošanai patoloģiska stāvokļa, kam raksturīga paaugstināta iNOS gēna ekspresija, profilaksei un ārstēšanai |
EP3127539A1 (fr) * | 2015-08-03 | 2017-02-08 | Latvian Institute Of Organic Synthesis | Utilisation de 2- (5s-methyl-2-oxo-4r-phenyl-pyrrolidin-1-yl) -acétamide dans le traitement de crises d'épilepsie |
WO2024049236A1 (fr) * | 2022-08-31 | 2024-03-07 | 고려대학교 산학협력단 | Dérivé de gamma lactame chiral ou sel pharmaceutiquement acceptable de celui-ci, et sa méthode de préparation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0004297D0 (en) * | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
RU2232578C1 (ru) | 2003-04-10 | 2004-07-20 | Ахапкина Валентина Ивановна | Вещество, обладающее антидепрессивной активностью |
RU2289404C1 (ru) * | 2005-04-06 | 2006-12-20 | ГОУ ВПО "Московский государственный медико-стоматологический университет Министерства здравоохранения РФ" | Способ премедикации у пациентов со средним уровнем психоэмоционального напряжения при амбулаторных стоматологических вмешательствах |
-
2006
- 2006-03-16 LV LVP-06-45A patent/LV13630B/en unknown
-
2007
- 2007-03-15 AT AT07726915T patent/ATE460396T1/de active
- 2007-03-15 ME MEP-2009-293A patent/ME01192B/fr unknown
- 2007-03-15 PL PL07726915T patent/PL2013166T3/pl unknown
- 2007-03-15 ES ES07726915T patent/ES2342024T3/es active Active
- 2007-03-15 EP EP07726915A patent/EP2013166B1/fr active Active
- 2007-03-15 EA EA200801978A patent/EA014668B1/ru not_active IP Right Cessation
- 2007-03-15 CA CA2647206A patent/CA2647206C/fr not_active Expired - Fee Related
- 2007-03-15 EE EEP200800063A patent/EE05536B1/xx not_active IP Right Cessation
- 2007-03-15 DK DK07726915.7T patent/DK2013166T3/da active
- 2007-03-15 DE DE602007005244T patent/DE602007005244D1/de active Active
- 2007-03-15 PT PT07726915T patent/PT2013166E/pt unknown
- 2007-03-15 CN CNA2007800177832A patent/CN101448786A/zh active Pending
- 2007-03-15 UA UAA200812099A patent/UA96440C2/ru unknown
- 2007-03-15 SI SI200730253T patent/SI2013166T1/sl unknown
- 2007-03-15 GE GEAP200710934A patent/GEP20104915B/en unknown
- 2007-03-15 WO PCT/EP2007/052424 patent/WO2007104780A2/fr active Application Filing
- 2007-03-15 US US12/226,332 patent/US9102615B2/en not_active Expired - Fee Related
-
2008
- 2008-09-22 LT LT2008075A patent/LT5589B/lt not_active IP Right Cessation
-
2009
- 2009-09-30 HR HRP20090524AA patent/HRP20090524C1/hr not_active IP Right Cessation
-
2010
- 2010-06-08 CY CY20101100506T patent/CY1110170T1/el unknown
-
2015
- 2015-04-16 US US14/688,633 patent/US9382203B2/en active Active
Non-Patent Citations (1)
Title |
---|
D.MASHKOVSKY: "Medicinal drugs", pages: 70 - 79 |
Also Published As
Publication number | Publication date |
---|---|
EP2013166B1 (fr) | 2010-03-10 |
LT2008075A (en) | 2009-06-25 |
EA014668B1 (ru) | 2010-12-30 |
DK2013166T3 (da) | 2010-07-05 |
SI2013166T1 (sl) | 2010-07-30 |
ME01192B (fr) | 2012-12-20 |
ES2342024T3 (es) | 2010-06-30 |
EE05536B1 (et) | 2012-04-16 |
HRP20090524A2 (hr) | 2009-12-31 |
US20150216846A1 (en) | 2015-08-06 |
GEP20104915B (en) | 2010-03-10 |
EP2013166A2 (fr) | 2009-01-14 |
US20100022784A1 (en) | 2010-01-28 |
EE200800063A (et) | 2008-12-15 |
HRP20090524C1 (hr) | 2017-03-10 |
CA2647206C (fr) | 2011-09-27 |
UA96440C2 (ru) | 2011-11-10 |
CY1110170T1 (el) | 2015-01-14 |
US9382203B2 (en) | 2016-07-05 |
ATE460396T1 (de) | 2010-03-15 |
CA2647206A1 (fr) | 2007-09-20 |
WO2007104780A2 (fr) | 2007-09-20 |
HRPK20090524B3 (hr) | 2012-12-31 |
DE602007005244D1 (de) | 2010-04-22 |
EA200801978A1 (ru) | 2009-04-28 |
US9102615B2 (en) | 2015-08-11 |
CN101448786A (zh) | 2009-06-03 |
PT2013166E (pt) | 2010-06-09 |
WO2007104780A3 (fr) | 2007-11-29 |
LV13630B (en) | 2007-12-20 |
PL2013166T3 (pl) | 2010-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LT5589B (lt) | N-karbamoilmetil-4-(r)-fenil-2-pirolidinonas, jo gavimo būdas ir farmacinis panaudojimas | |
TWI286132B (en) | 4-pyrrolidino-phenyl-benzyl ether derivatives | |
JPS62190160A (ja) | (−)−ベンツヒドリルスルフイニルアセトアミド及びその製法 | |
Baures et al. | Crystal structure, absolute configuration, and phosphodiesterase inhibitory activity of (+)-1-(4-bromobenzyl)-4-[(3-cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone | |
US9714239B2 (en) | N-phenyl-lactam derivatives capable of stimulating neurogenesis and their use in the treatment of neurological disorders | |
HRP20120166T1 (hr) | Supstituirane n-bipirolidinuree i njihova upotreba u terapiji | |
JP5377473B2 (ja) | 高純度の2,4’−ジメチル−3−ピペリジノ−プロピオフェノン(トルペリゾン)、これを含む医薬品組成物の製造法、並びにトルペリゾン含有活性物質組成物 | |
FI934752A0 (fi) | Substituerade kinuklidiner | |
TNSN04156A1 (fr) | Pyridinones substituees servant de modulateurs de la map-kinase p38 | |
RU2008123376A (ru) | Производные 4-(4-алкокси-3-гидроксифенил)-2-пирролидона в качестве ингибиторов pde-4 для лечения неврологических синдромов | |
DE60219954D1 (de) | Neue Indol-2-on Derivate | |
Galman et al. | Biomimetic synthesis of 2-substituted N-heterocycle alkaloids by one-pot hydrolysis, transamination and decarboxylative Mannich reaction | |
AP1016A (en) | Pyrrolidinyl and pyrrolinyl ethylamine compounds as opioid kappa receptor agonists. | |
EP4125840A1 (fr) | Composés destinés à être utilisés dans le traitement de synucléinopathies | |
TWI291349B (en) | Benzyloxy derivatives as MAOB inhibitors | |
Wang et al. | Synthesis and immunosuppressant activity of pyrazole carboxamides | |
ATE289583T1 (de) | Stereoisomere von propyl-isopropylacetamid, verfahren zu deren herstellung sowie diese enthaltende pharmazeutische zubereitungen | |
KR20210014164A (ko) | 히스타민-3 수용체 역작용제에 의한 치료 방법 | |
US20230016922A1 (en) | Visible-light mediated organophotoredox catalytic deuteration of aromatic and aliphatic aldehydes | |
US11584710B2 (en) | Compounds for treating infections | |
ATE315023T1 (de) | Aminoalkylpyrrolidine als serotoninrezeptorliganden sowie diese enthaltende zusammensetzungen, pharmazeutische verwendungen und methoden zu deren synthese | |
LV14346B (lv) | 2-(4-Fenil-5-metil-2-oksopirolidin-1-il)-acetamīda 4R,5S-enantiomērs ar nootropo aktivitāti | |
TW410217B (en) | Substituted N-arylmethylamino derivatives of cyclobutene-3,4-diones | |
US6060516A (en) | N1 -propargylhydrazines, N2 -propargylhydrazines and their analogs for the treatment of depression, anxiety and neurodegeneration | |
CHANG et al. | New Synthesis of Β-Aryl-Gaba Drugs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM9A | Lapsed patents |
Effective date: 20160315 |